BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Endothelial cell
,
Pharmacogenetics
,
Cisplatin
,
rs4950928
,
PRKCA
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antimuscarinic agents
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
ATF3
FOS
CHRM2
CHRM1
CYP51A1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
response to organic substance
regulation of nitrogen compound metabolic process
organic cyclic compound metabolic process
organic cyclic compound binding
heterocyclic compound binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Breast cancer MCF7 cells treated with 102 traditional Chinese medicinal components
Cerebrocortical cells treated with blood-brain barrier penetrant clinic-tested drugs
Brain gene expression following exposure to the oganophosphonate anti-cholinesterase Sarin
Hearts of rats exposed variety of toxicants
Liver tissues from rats after treatment with different compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Pharmacist-driven interventions to de-escalate urinary antimuscarinics in the Programs of All-Inclus…
Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study.
The cognitive safety of antimuscarinics in the treatment of overactive bladder.
Antimuscarinics for neurogenic overactive bladder in multiple sclerosis: real-life data.
Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactiv…
Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome
Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1
Bladder Antimuscarinic Medication and Accidental Bowel Leakage
Transcutaneous Tibial Nerve Stimulation in Antimuscarinic Naive and Refractory Women With Idiopathic…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ